Nxera Pharma Balance Sheet Health
Financial Health criteria checks 2/6
Nxera Pharma has a total shareholder equity of ¥66.8B and total debt of ¥69.2B, which brings its debt-to-equity ratio to 103.5%. Its total assets and total liabilities are ¥157.2B and ¥90.4B respectively.
Key information
103.5%
Debt to equity ratio
JP¥69.16b
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥49.38b |
| Equity | JP¥66.81b |
| Total liabilities | JP¥90.39b |
| Total assets | JP¥157.20b |
Financial Position Analysis
Short Term Liabilities: 4565's short term assets (¥65.1B) exceed its short term liabilities (¥17.2B).
Long Term Liabilities: 4565's short term assets (¥65.1B) do not cover its long term liabilities (¥73.2B).
Debt to Equity History and Analysis
Debt Level: 4565's net debt to equity ratio (29.6%) is considered satisfactory.
Reducing Debt: 4565's debt to equity ratio has increased from 16.7% to 103.5% over the past 5 years.
Debt Coverage: 4565's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 4565's interest payments on its debt are well covered by EBIT.